Molecular pathways: is AMPK a friend or a foe in cancer?

Research output: Contribution to journalArticle

75 Citations (Scopus)
139 Downloads (Pure)

Abstract

The AMP-activated protein kinase (AMPK) is a sensor of cellular energy status expressed in essentially all eukaryotic cells. Once activated by energetic stress via a mechanism that detects increases in AMP:ATP and ADP:ATP ratios, AMPK acts to restore energy homeostasis by switching on catabolic pathways that generate ATP, while switching off ATP-consuming processes, including anabolic pathways required for cell growth and proliferation. AMPK activation promotes the glucose-sparing, oxidative metabolism utilized by most quiescent cells, rather than the rapid glucose uptake and glycolysis used by most proliferating cells. Numerous pharmacologic activators of AMPK are known, including drugs in long use such as salicylate and metformin, and there is evidence that regular use of either of the latter provides protection against development of cancer. Tumor cells appear to be under selection pressure to downregulate AMPK, thus limiting its restraining influence on cell growth and proliferation, and several interesting mechanisms by which this occurs are discussed. Paradoxically, however, a complete loss of AMPK function, which appears to be rare in human cancers, may be deleterious to survival of tumor cells. AMPK can therefore be either a friend or a foe in cancer, depending on the context. Clin Cancer Res; 21(17); 3836-40. ©2015 AACR.

Original languageEnglish
Pages (from-to)3836-3840
Number of pages5
JournalClinical Cancer Research
Volume21
Issue number17
DOIs
Publication statusPublished - 1 Sep 2015

Fingerprint Dive into the research topics of 'Molecular pathways: is AMPK a friend or a foe in cancer?'. Together they form a unique fingerprint.

  • Projects

    Cite this